Advisor Group Holdings, Inc. Agios Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 35 shares of AGIO stock, worth $1,142. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 286
87.76%
Holding current value
$1,142
Previous $9,000
88.89%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$186 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$183 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$159 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$115 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$79.9 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.79B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...